Implementing daily chlorhexidine gluconate (CHG) bathing in VA settings: The human factors engineering to prevent resistant organisms (HERO) project.
Implementing daily chlorhexidine gluconate (CHG) bathing in VA settings: The human factors engineering to prevent resistant organisms (HERO) project.
复制标题
DOI:
10.1016/j.ajic.2020.12.012
复制
发表时间:
2021-06
影响因子:
4.9
通讯作者:
Safdar, Nasia
中科院分区:
文献类型:
--
作者:
Knobloch, Mary Jo;Musuuza, Jackson S.;McKinley, Linda;Zimbric, Michele L.;Baubie, Kelsey;Hundt, Ann Schoofs;Carayon, Pascale;Hagle, Mary;Pfeiffer, Christopher D.;Galea, Marinella D.;Crnich, Christopher J.;Safdar, Nasia
关键词:
Daily use of chlorhexidine gluconate (CHG) has been shown to reduce risk of healthcare-associated infections. We aimed to assess moving CHG bathing into routine practice using a human factors approach. We evaluated implementation in non-intensive care unit (ICU) settings in the Veterans Health Administration. Our multiple case study approach included non-ICU units from 4 Veterans Health Administration settings. Guided by the Systems Engineering Initiative for Patient Safety, we conducted focus groups and interviews to capture barriers and facilitators to daily CHG bathing. We measured compliance using observations and skin CHG concentrations. Barriers to daily CHG include time, concern of increasing antibiotic resistance, workflow and product concerns. Facilitators include engagement of champions and unit shared responsibility. We found shortfalls in patient education, hand hygiene and CHG use on tubes and drains. CHG skin concentration levels were highest among patients from spinal cord injury units. These units applied antiseptic using 2% CHG impregnated wipes vs 4% CHG solution/soap. Non-ICUs implementing CHG bathing must consider human factors and work system barriers to ensure uptake and sustained practice change. Well-planned rollouts and a unit culture promoting shared responsibility are key to compliance with daily CHG bathing. Successful implementation requires attention to staff education and measurement of compliance.
登录
查看更多内容
DOI:
10.1056/nejmoa1113849
发表时间:
2013-02-07
期刊:
The New England journal of medicine
影响因子:
--
作者:
Climo MW;Yokoe DS;Warren DK;Perl TM;Bolon M;Herwaldt LA;Weinstein RA;Sepkowitz KA;Jernigan JA;Sanogo K;Wong ES
通讯作者:
Wong ES
DOI:
10.1186/1748-5908-4-50
发表时间:
2009-08-07
期刊:
Implementation science : IS
影响因子:
--
作者:
Damschroder LJ;Aron DC;Keith RE;Kirsh SR;Alexander JA;Lowery JC
通讯作者:
Lowery JC
DOI:
10.1016/j.jamcollsurg.2007.12.054
发表时间:
2008-08-01
影响因子:
5.2
作者:
Edmiston, Charles E., Jr.;Krepel, Candace J.;Towne, Jonathan B.
通讯作者:
Towne, Jonathan B.
影响因子:
158.5
作者:
Huang, Susan S.;Septimus, Edward;Platt, Richard
通讯作者:
Platt, Richard
影响因子:
3.2
作者:
Carayon, Pascale;Wetterneck, Tosha B.;Gurses, Ayse P.
通讯作者:
Gurses, Ayse P.